Pay-For-Delay Practice Case Cost Americans $3.5 Billion: Supreme Court To Weigh In

(MintPress) – Ever wonder why some prescription drugs have generic competitors and others don’t? Part of it is because pharmaceutical companies have been giving generous financial incentives to generic drug competitors to delay the release of cheaper versions of brand-name drugs — and now federal regulators are pressing the Supreme Court to step in and […]

Sign Up For The Best Of MintPress, Delivered To Your Daily Inbox.

Sign up for our daily digest.